SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001511164-14-000657
Filing Date
2014-11-14
Accepted
2014-11-14 14:40:41
Documents
9
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q wppgisept1410q.htm 10-Q 273996
2 CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER exhibit311.htm EX-31.1 7118
3 CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER exhibit321.htm EX-32.1 4485
  Complete submission text file 0001511164-14-000657.txt   2775945

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT pang-20140930.xml EX-101.INS 418793
5 XBRL TAXONOMY EXTENSION SCHEMA pang-20140930.xsd EX-101.SCH 34394
6 XBRL TAXONOMY EXTENSION CALULATION LINKBASE pang-20140930_cal.xml EX-101.CAL 2866
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pang-20140930_def.xml EX-101.DEF 65151
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE pang-20140930_lab.xml EX-101.LAB 128056
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pang-20140930_pre.xml EX-101.PRE 128686
Mailing Address 330 HIGHWAY 7 EAST SUITE 502 RICHMOND HILL A6 L4B 3P8
Business Address 330 HIGHWAY 7 EAST SUITE 502 RICHMOND HILL A6 L4B 3P8 714-418-1414
Panacea Global, Inc. (Filer) CIK: 0001024048 (see all company filings)

IRS No.: 330680443 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30424 | Film No.: 141223100
SIC: 8071 Services-Medical Laboratories